Tradestie Institutional Equity Comparison Engine · Market Close Nov 17, 2026

DGII vs CAMP: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

DGII Wins Head-to-Head Institutional Verdict (6–0 across 6 Pillars · 8–2 Matrix Metrics)

DGII Overall Winner 6-Pillar Tally: DGII 6 – 0 CAMP Matrix Metrics: DGII 8 – 2 CAMP

As of Nov 17, 2026, Digi International Inc (DGII) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGII carries a Unified Composite Score of 42.1/100 (HOLD) at $53.26 (15.1x Forward P/E, 14.9% operating margin), whereas CAMP carries 43.9/100 (HOLD) at $4.00 (N/M Forward P/E, -991.8% operating margin).

  • Composite vs. Pillar Nuance: While CAMP currently prints a higher short-term Unified Composite Score (43.9/100 HOLD vs. DGII 42.1/100 HOLD), DGII captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (14.9% vs. -991.8% operating margin) and revenue trajectory (+25.3% vs. +138.9% YoY).
  • Technical & Structure Timing Caution: DGII is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.6); meanwhile CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About DGII vs CAMP
DGII NASDAQ Head-to-Head Winner
Digi International Inc
Computer Communications Equipment
$53.26
+0.6% 1D
Market Cap $2.1B
TTM Revenue $535M
Forward P/E 15.1x
Beta / 30D Vol 1.93β · 78% Vol
Unified Composite Score
42.1 / 100 HOLD
Tech 35.0 Fund 40.0 Flow 54.0 Mom 40.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -4.4%), weak momentum, RSI 28
RSI-14: 27.6 · SMA20: $68.40 · SMA50: $71.35
CAMP NASDAQ
CAMP4 Therapeutics Corporation Common Stock
Pharmaceutical Preparations
$4.00
+3.63% 1D
Market Cap $238.5M
TTM Revenue $5.3M
Forward P/E N/M
Beta / 30D Vol 1.35β · 94% Vol
Unified Composite Score
43.9 / 100 HOLD
Tech 34.0 Fund 40.0 Flow 50.0 Mom 40.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 52
RSI-14: 51.9 · SMA20: $3.82 · SMA50: $3.84

6-Pillar Scorecard Institutional Category Breakdown (DGII 6 – 0 CAMP)

Columns: Metric · DGII · CAMP
1. Valuation Multiples DGII
Forward P/E 15.1x N/M
Trailing P/E 40.2x N/M
PEG Ratio 0.83x N/M
EV / Revenue 3.9x 26.6x
2. Growth & Scale DGII
Revenue Growth (YoY) +25.3% +138.9%
Earnings Growth (YoY) +45.6% +0.0%
TTM Revenue (USD) $535M $5.3M
Market Cap $2.1B $238.5M
3. Profitability & Quality DGII
Gross Margin 63.8% N/A
Operating Margin 14.9% -991.8%
Net Profit Margin 10.0% 0.0%
Return on Equity (ROE) 8.0% -146.1%
4. Balance Sheet & Cash Flow DGII
Cash Generation (TTM) $125M EBITDA -$26M
Cash Flow Margin 23.3% EBITDA Mgn N/A
Net Cash / Leverage $18.58 Book/Sh · 8.0% ROE $97M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning DGII
Options Structure Phase CONSOLIDATION UNCLASSIFIED
Current IV / %ile 50.6% (9th %ile) N/A (N/A)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase DISTRIBUTION · Markdown NEUTRAL · Neutral
6. R&D & Supply-Chain Moat DGII
OpEx & R&D Intensity 48.9% of Rev ($262M) N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Communication Equipment Operator Biotechnology Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: DGII (8) vs CAMP (2)
Institutional Metric DGII CAMP Criterion Row Edge
Market Capitalization
Scale
$2.1B $238.5M Larger Scale DGII
Trailing P/E Ratio
Valuation
40.2x N/M Lower Multiple DGII
Forward P/E Ratio
Valuation
15.1x N/M Lower Multiple DGII
Revenue Growth (YoY)
Growth
+25.3% +138.9% Higher Growth CAMP
Operating Margin (TTM)
Profitability
14.9% -991.8% Higher Margin DGII
Net Profit Margin
Profitability
10.0% 0.0% Higher Margin DGII
Return on Equity (ROE)
Capital Efficiency
8.0% -146.1% Higher ROE DGII
52-Week Range Position
Momentum
33% ($37–$87) 23% ($3–$8) Stronger Trend DGII
Beta / 30D Volatility
Risk Regime
1.93β · 78% Vol 1.35β · 94% Vol Lower Realized Risk DGII
Unified Institutional Score
Composite Signal
42.1 / 100 (HOLD) 43.9 / 100 (HOLD) Higher Composite CAMP
Trailing 12M Revenue (USD)
Operating Scale
$535M $5.3M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
63.8% N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.83x PEG · 3.9x EV/Rev N/M PEG · 26.6x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$125M EBITDA ($18.58 Book/Sh · 8.0% ROE) -$26M ($97M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon CAMP +54.65 pp
DGII: -27.26% · CAMP: +27.39%
3M Horizon CAMP +16.02 pp
DGII: -30.0% · CAMP: -13.98%
6M Horizon CAMP +9.72 pp
DGII: -13.33% · CAMP: -3.61%
1Y Horizon DGII +41.21 pp
DGII: +38.77% · CAMP: -2.44%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period DGII Revenue CAMP Revenue DGII Op. Margin CAMP Op. Margin Margin Leader
FY2018 $230M N/A 1.2% N/A DGII
FY2019 $250M N/A 4.0% N/A DGII
FY2020 $280M N/A 4.1% N/A DGII
FY2021 $310M N/A 3.4% N/A DGII
FY2022 $390M N/A 9.8% N/A DGII
FY2023 $440M $0M 11.3% -14822.6% DGII
FY2024 $420M $0M 11.3% -8142.3% DGII
FY2025 $430M $0M 13.1% -1502.4% DGII

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
DGII CONSOLIDATION
117d in phase · OBV DISTRIBUTION
Current IV 50.6%
IV Percentile 9th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow DISTRIBUTION
Exact DGII Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
CAMP UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact CAMP Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
DGII Moat Profile Cyclical / Execution-Driven Positioning
Communication Equipment Operator
Competes within the Communication Equipment value chain with $2.1B market capitalization and 14.9% operating margin.
OpEx & R&D Reinvestment 48.9% of Rev ($262M)
90D Engineering Disclosures 0 Published
CAMP Moat Profile Cyclical / Execution-Driven Positioning
Biotechnology Operator
Competes within the Biotechnology value chain with $238.5M market capitalization and -991.8% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ DGII vs CAMP Key Questions & Quantitative Answers

As of Nov 17, 2026, Digi International Inc (DGII) is the stronger overall head-to-head candidate over CAMP4 Therapeutics Corporation (CAMP) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 6–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). DGII carries a Unified Composite Score of 42.1/100 (HOLD) at $53.26 (15.1x Forward P/E, 14.9% operating margin), whereas CAMP carries 43.9/100 (HOLD) at $4.00 (N/M Forward P/E, -991.8% operating margin). Composite vs. Pillar Nuance: While CAMP currently prints a higher short-term Unified Composite Score (43.9/100 HOLD vs. DGII 42.1/100 HOLD), DGII captures the overall institutional head-to-head verdict (8–2 matrix metrics and 6–0 across the 6 pillars) due to superior fundamental profitability (14.9% vs. -991.8% operating margin) and revenue trajectory (+25.3% vs. +138.9% YoY). Technical & Structure Timing Caution: DGII is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 27.6); meanwhile CAMP trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 51.9). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

DGII leads the Growth & Scale pillar: DGII posts +25.3% YoY revenue growth and +45.6% YoY earnings growth on $535M TTM revenue (63.8% gross margin, 14.9% operating margin), compared with CAMP at +138.9% YoY revenue growth and +0.0% YoY earnings growth on $5.3M TTM revenue (N/A gross margin, -991.8% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), DGII cumulative revenue shifted +87.0% while CAMP shifted N/A. In operating R&D and SG&A reinvestment, DGII deploys 48.9% of Rev ($262M) (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for CAMP.

DGII screens cheaper on headline valuation multiples. DGII trades at 15.1x Forward P/E, 40.2x Trailing P/E, 0.83x PEG, and 3.9x EV/Revenue (23.3% EBITDA margin), whereas CAMP trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 26.6x EV/Revenue (unreported FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against DGII (8.0% ROE) versus CAMP (-146.1% ROE) capital efficiency.

In options market volatility and institutional positioning, DGII carries 50.6% implied volatility (9th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, DISTRIBUTION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.93β · 78% Vol realized risk). By comparison, CAMP carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (1.35β · 94% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 17, 2026. For educational research only; not investment advice.